Ibutilide
Corvert (ibutilide) is a small molecule pharmaceutical. Ibutilide was first approved as Corvert on 1995-12-28. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. The pharmaceutical is active against potassium voltage-gated channel subfamily H member 2.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Corvert (generic drugs available since 2010-01-11)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ibutilide fumarate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORVERT | Mylan | N-020491 RX | 1995-12-28 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| corvert | New Drug Application | 2021-01-25 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| atrial fibrillation | EFO_0000275 | D001281 | I48.0 |
| atrial flutter | EFO_0003911 | D001282 | — |
| cardiac arrhythmias | EFO_0004269 | D001145 | I49.9 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J1742 | Injection, ibutilide fumarate, 1 mg |
Clinical
Clinical Trials
628 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | 12 | 12 | 25 | 27 | 13 | 88 |
| Postoperative pain | D010149 | G89.18 | 4 | 8 | 13 | 22 | 12 | 58 | |
| Healthy volunteers/patients | — | 38 | — | — | 3 | 2 | 43 | ||
| Patent ductus arteriosus | D004374 | HP_0001643 | Q25.0 | 2 | 9 | 10 | 9 | 12 | 39 |
| Fever | D005334 | HP_0001945 | R50.9 | 2 | — | 5 | 10 | 3 | 20 |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | 2 | 4 | 10 | 2 | 17 |
| Acute pain | D059787 | R52 | 2 | 2 | 5 | 7 | 1 | 17 | |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 3 | 3 | 6 | 2 | — | 14 |
| Analgesia | D000698 | — | 2 | 6 | 6 | — | 13 | ||
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 3 | 2 | — | 3 | 3 | 10 |
Show 86 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | — | 2 | 1 | — | 1 | 4 | |
| Local anesthesia | D000772 | — | 2 | 1 | — | 1 | 3 | ||
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | 1 | — | 1 | 3 |
| Altitude sickness | D000532 | EFO_1000782 | T70.29 | 1 | — | 1 | — | 1 | 3 |
| Impacted tooth | D014095 | HP_0011079 | K01.1 | — | 1 | 2 | — | 1 | 3 |
| Sprains and strains | D013180 | — | — | 3 | — | — | 3 | ||
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | 1 | — | — | 2 |
| Cachexia | D002100 | HP_0004326 | R64 | — | — | 1 | — | 1 | 2 |
| Musculoskeletal pain | D059352 | — | 1 | 1 | — | — | 2 | ||
| Ankle injuries | D016512 | S93.4 | — | — | 1 | — | 1 | 2 |
Show 39 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 2 | — | — | — | 2 |
| Phimosis | D010688 | EFO_1001104 | N47.1 | 1 | 1 | — | — | — | 2 |
| Paraphimosis | D010263 | EFO_1001086 | N47.2 | 1 | 1 | — | — | — | 2 |
| Balanitis | D001446 | EFO_1000833 | N48.1 | 1 | 1 | — | — | — | 2 |
| Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | — | 1 | — | — | 1 | 2 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | 2 | — | — | — | 2 |
| Abdominal hernia | D046449 | K46 | — | 1 | — | — | 1 | 2 | |
| Bronchopulmonary dysplasia | D001997 | P27.8 | — | 2 | — | — | — | 2 | |
| Soft tissue injuries | D017695 | — | 1 | — | — | 1 | 2 | ||
| Temporomandibular joint disorders | D013705 | M26.6 | 1 | 1 | — | — | 1 | 2 |
Show 28 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | 4 | — | — | — | — | 4 | ||
| Pharmacokinetics | D010599 | 1 | — | — | — | 1 | 2 | ||
| Drug interactions | D004347 | 1 | — | — | — | — | 1 | ||
| Pure autonomic failure | D054970 | 1 | — | — | — | — | 1 | ||
| Orthostatic hypotension | D007024 | I95.1 | 1 | — | — | — | — | 1 | |
| Hematologic neoplasms | D019337 | 1 | — | — | — | — | 1 | ||
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 1 | — | — | — | — | 1 | |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 1 | — | — | — | — | 1 | |
| Hodgkin disease | D006689 | C81 | 1 | — | — | — | — | 1 | |
| Systemic mastocytosis | D034721 | C96.21 | 1 | — | — | — | — | 1 |
Show 10 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | — | 3 | 3 |
| Leg ulcer | D007871 | — | — | — | — | 2 | 2 | ||
| Colonic neoplasms | D003110 | C18 | — | — | — | — | 1 | 1 | |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
| Urinary calculi | D014545 | N20.9 | — | — | — | — | 1 | 1 | |
| Pediatric obesity | D063766 | — | — | — | — | 1 | 1 | ||
| Appetitive behavior | D001070 | — | — | — | — | 1 | 1 | ||
| Platelet aggregation | D010974 | GO_0070527 | — | — | — | — | 1 | 1 | |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 1 | 1 |
| Forearm injuries | D005543 | S59.91 | — | — | — | — | 1 | 1 |
Show 48 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | IBUTILIDE |
| INN | ibutilide |
| Description | Ibutilide is an organic amino compound and a member of benzenes. |
| Classification | Small molecule |
| Drug class | class III antiarrhythmic agents |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 122647-31-8 |
| RxCUI | 41289 |
| ChEMBL ID | CHEMBL533 |
| ChEBI ID | 5856 |
| PubChem CID | 60753 |
| DrugBank | DB00308 |
| UNII ID | 2436VX1U9B (ChemIDplus, GSRS) |
Target
Agency Approved
KCNH2
KCNH2
Organism
Homo sapiens
Gene name
KCNH2
Gene synonyms
ERG, ERG1, HERG
NCBI Gene ID
Protein name
potassium voltage-gated channel subfamily H member 2
Protein synonyms
Eag homolog, Eag-related protein 1, ERG-1, Ether-a-go-go-related gene potassium channel 1, ether-a-go-go-related potassium channel protein, Ether-a-go-go-related protein 1, H-ERG, hERG-1, hERG1, human ether-a-go-go-related, long QT syndrome type 2, potassium channel, voltage gated eag related subfamily H, member 2, potassium voltage-gated channel, subfamily H (eag-related), member 2, Voltage-gated potassium channel subunit Kv11.1
Uniprot ID
Mouse ortholog
Kcnh2 (16511)
potassium voltage-gated channel subfamily H member 2 (O35219)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 875 documents
View more details
Safety
Black-box Warning
Black-box warning for: Corvert
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
82,777 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more